Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review

Abstract Background The prognosis for patients with advanced differentiated thyroid carcinoma (ADTC) with disseminated distant metastases is very poor. Tyrosine kinase inhibitors targeting tumor angiogenesis have been shown to improve progression-free survival in patients with advanced thyroid carci...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Nai-Wei Sheu, He-Jiun Jiang, Che-Wei Wu, Feng-Yu Chiang, Hsin-Ying Clair Chiou, Pi-Jung Hsiao
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2019-05-01
Ráidu:	World Journal of Surgical Oncology
Fáttát:	Advanced thyroid carcinoma Lenvatinib Tyrosine kinase inhibitor (TKI)
Liŋkkat:	http://link.springer.com/article/10.1186/s12957-019-1626-4
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!